Nessan Bermingham

Insider Reports History

Location
Waltham, MA
Signature
/s/ Jeffrey Cerio, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nessan Bermingham:

Company Role Class Num Shares Value Price $ Report Date Ownership
Korro Bio, Inc. Director Stock Option (Right to Buy) 6,010 11 Jun 2025 Direct
F-star Therapeutics, Inc. Director Common Stock 0 $7.12 08 Mar 2023 Direct
F-star Therapeutics, Inc. Director Stock Option (right to buy) 0 08 Mar 2023 Direct

Insider Reports Filed by Nessan Bermingham

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KRRO Korro Bio, Inc. 11 Jun 2025 1 $0 4 Director 12 Jun 2025, 16:29
KRRO Korro Bio, Inc. 11 Jun 2024 1 $0 4 Director 12 Jun 2024, 17:17
KRRO Korro Bio, Inc. 03 Nov 2023 3 $0 4 Director 07 Nov 2023, 21:15
KRRO Korro Bio, Inc. 03 Nov 2023 0 $0 3 Director 07 Nov 2023, 21:03
/report/000089924323007657-bermingham-nessan-2023-03-08 F-star Therapeutics, Inc. 08 Mar 2023 5 -$739,590 4 Director 09 Mar 2023, 08:12
/report/000120919122038714-bermingham-nessan-2022-06-17 F-star Therapeutics, Inc. 17 Jun 2022 1 $0 4 Director 22 Jun 2022, 17:11
/report/000120919121038563-bermingham-nessan-2021-06-04 F-star Therapeutics, Inc. 04 Jun 2021 1 $0 4 Director 07 Jun 2021, 16:12
/report/000120919121053233-bermingham-nessan-2020-11-20-restatement F-star Therapeutics, Inc. 20 Nov 2020 1 $0 4/A Director 24 Aug 2021, 18:34